No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Institutional Investors Control 71% of RxSight, Inc. (NASDAQ:RXST) and Were Rewarded Last Week After Stock Increased 6.0%
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Is It Too Late To Consider Buying RxSight, Inc. (NASDAQ:RXST)?
RxSight Insider Sold Shares Worth $906,288, According to a Recent SEC Filing
Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)
RxSight(RXST.US) Director Sells US$906.29K in Common Stock